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Abstract
Background: Medication non-adherence is a major contributor to poor outcomes in diabetes. Previous research
has shown an association between use of mail order pharmacy delivery and better medication adherence, but little
is known about the barriers and facilitators to mail order pharmacy use in diabetes patients. This qualitative study
examined factors related to mail order pharmacy use versus traditional “brick and mortar” pharmacies to refill
prescriptions.
Methods: We conducted four 90-min focus groups in 2016 among 28 diabetes patients in the Hawaii and Northern
California regions of Kaiser Permanente, a large integrated health care delivery system. We queried participants on their
preferred mode for refilling prescriptions and perceived barriers and facilitators of mail order pharmacy use. One
researcher independently coded each focus group transcript, with two of these transcripts double-coded by a second
researcher to promote reliability. We employed thematic analysis guided by the Capability, Opportunity, Motivation,
and Behavior (COM-B) framework using NVivo 11 software.
Results: A total of 28 diabetes patients participated. Participants’ average age was 64.1 years; 57% were female; and
racial/ethnic backgrounds included Asian/Native Hawaiian/Pacific Islander (36%), Black/African-American (21%)
Hispanic/Latino (7%), and non-Hispanic White (36%). Analysis uncovered 26 themes related to the decision to use mail
order pharmacy, with each theme representing a barrier or facilitator mapped to the COM-B framework. Most themes
(20/26) fell into the COM-B category of ‘Opportunity.’ Opportunity barriers to mail order pharmacy use included
unpredictability of medication delivery date, concerns about mail security, and difficulty coordinating refill orders for
multiple prescriptions. In contrast, facilitators included greater access and convenience (e.g., no need to wait in line or
arrange transportation) compared to traditional pharmacies. Motivational facilitators to mail order pharmacy use
included receiving a pharmacy benefit plan incentive of a free one-month supply of prescriptions.
Conclusions: This study found that while patients with diabetes may benefit from mail order pharmacy use, they
perceive numerous barriers to using the service. These findings will inform the design of interventions and quality
improvement initiatives to increase mail order pharmacy use, which in turn may improve medication adherence and
outcomes in diabetes patients, across health care systems.
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Background
Over 30 million Americans have type 2 diabetes [1], a
condition associated with significant mortality and mor-
bidity. Diabetes is currently the seventh leading cause of
death in the United States [2], and the number of adults
with the disease has gone up dramatically in the past
two decades [3].
Good medication adherence is associated with improved
health outcomes, fewer hospitalizations, and lower mor-
tality in patients with diabetes [4–6]. However, only 50–
70% of patients with chronic conditions are adherent to
their regular medications [7–9]. Numerous studies have
shown significant disparities in medication adherence
among diabetes patients; minorities and low socioeco-
nomic status (SES) patients with diabetes have poorer ad-
herence to cardiometabolic medications shown to reduce
diabetes complications [10–15].
Use of mail order pharmacy services to deliver medica-
tions, or mail order pharmacy use, accounts for at least an
estimated 25% of pharmacy sales in the US, and rates are
even higher among Americans ages 65 and up [16].
Growth in mail order pharmacy services for outpatient
prescription drugs has increased significantly since the
1980s; prior to this time, community-based pharmacies
only occasionally offered ad hoc home delivery of medica-
tions to small, selected groups of patients based on factors
such as patient home address and mobility [16]. A grow-
ing body of research suggests that mail order pharmacy
use is correlated with better medication adherence in dia-
betes [17–21] and across a wide range of chronic condi-
tions [21–26]. Mail order pharmacy use is also associated
with better health care outcomes and decreased health
care utilization and costs [18, 23, 27–29]. Patients who
use mail order pharmacy are more likely to be non-
Hispanic White and have higher SES [17, 28]. Encour-
aging mail order pharmacy use in diverse populations may
be an important tool for reducing disparities in health care
outcomes [25].
Despite the evidence that mail order pharmacy may be
an important strategy for improving diabetes care and
outcomes, there is little to no published evidence identify-
ing factors that influence patients’ uptake of this service.
This qualitative study sought to identify and describe facil-
itators and barriers to mail order pharmacy use among
diverse diabetes patients across two health systems. The
purpose of this study was to inform patient outreach strat-
egies for a pragmatic clinical trial designed to increase
mail order pharmacy use among diabetes patients (clinical
trial.gov registration number NCT02621476).
Methods
Study setting
This study is set within two health care delivery systems
that represent significant geographic, demographic, and
structural diversity. Kaiser Permanente Northern Cali-
fornia (KPNC) is a non-profit, integrated, group-model
health care delivery system that in 2016 served close to
4 million members in a 13-county area of Northern Cali-
fornia. This population is more than 30% non-white,
20% have attained a high school or lower level of educa-
tion, and almost 50% have a household income <$50 K
annually. Kaiser Permanente Hawaii (KPHI) is a non-
profit, mixed model health maintenance organization
that in 2016 served nearly 230,000 members throughout
Hawaii. This population is 70% non-white, representing
one of the most ethnically and racially diverse popula-
tions in the United States; 16% have attained a high
school or lower level of education, and about 45% have a
household income <$50 K annually. The patient mem-
bership of both health systems is representative of the
demographic characteristics of the geographic areas the
health systems serve.
Mail order pharmacy use at Kaiser Permanente (KP)
KPNC and KPHI have over 120 local “brick and mortar”
pharmacies, located on-site within outpatient clinics and
hospital facilities. KPNC and KPHI both maintain KP-
run mail-order pharmacy distribution systems in coord-
ination with the local KP pharmacies. Although most
new prescriptions are filled in the local KP pharmacy,
KP patients can elect to receive their prescription refills
sent via mail order pharmacy, ordered either through
the online patient portal (kp.org) or a toll-free pharmacy
refill telephone service. KP patients have telephone ac-
cess to a pharmacist to answer any medication-related
questions one-on-one regardless of whether a refill was
dispensed via mail order pharmacy or a local KP phar-
macy. There is no minimum days’ supply required for
mail order delivery. KP typically dispenses 90–100 day
medication supplies for most oral diabetes prescriptions
through both mail order and local KP pharmacies. Some
patients have a financial incentive to use mail order
pharmacy through their health insurance pharmacy
benefit structure. This is typically receiving 3 copay-
ments’ worth of medication for the price of 2 copay-
ments (e.g., 3 months’ supply for the price of 2 months’
supply) when the medications are refilled by mail.
Study participants
Potential participants were identified using KPNC and
KPHI electronic health record data. Patients were con-
sidered eligible if they had one primary inpatient diagno-
sis or 2 outpatient diagnoses of type 2 diabetes (ICD9
codes 250.xx, 357.2, 362.0x, 366.41), were adults ages
18–89, and had filled an oral diabetes medication
prescription (alpha-glucosidase inhibitor, amylin analog,
biguanide, glucagon-like peptide-1 (GLP-1) receptor
agonist, meglitinide, sodium-glucose cotransporter-2
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(SGL2) inhibitor, sulfonylurea, thiazolidinedione (TZD))
between 7/1/2014 and 6/30/2015. Insulin users who had
filled one of these oral diabetes medication prescriptions
were included; insulin-only users were excluded. Since
the study was conducted in English, non-English
speakers were excluded. To identify influences on the
use of both mail order and local pharmacies, we sought
the perspectives of both current mail order pharmacy
users and non-users. We defined mail order pharmacy
users as those who had used the mail order pharmacy at
least once during the 12-month period prior to recruit-
ment using KP prescription refill databases; the 12-
month window was used to reduce recall bias when
patients conveyed their experiences with the service.
Study design and implementation
Patients were recruited via mailed letter and telephone
outreach and offered $50 as an incentive for participa-
tion. We invited patients to participate in one of four
90-min focus groups in February and March of 2016, in
either Oakland, CA (KPNC) or Honolulu, HI (KPHI).
We used a 2 (site: KPNC vs. KPHI) × 2 (mail order phar-
macy user vs. non-user) design to examine patient per-
spectives across health systems and across levels of
familiarity with mail order pharmacy. We selected focus
group methodology to elicit a broad range of unique
ideas (rather than promote consensus) and to identify
concepts that may inform future interventions promot-
ing uptake of mail order pharmacy services. Participants
provided written informed consent.
The research team included professionals from health
services, public health, epidemiology, medicine, behav-
ioral science, pharmacy, clinical administration, and pro-
ject management backgrounds. This purposefully
interdisciplinary team fostered our ability to identify a
range of potential influences on mail order pharmacy
use. Focus groups were conducted by three trained facil-
itators, one in KPNC and two in KPHI. The researchers,
including interviewers, were unknown to research par-
ticipants prior to data collection. To improve neutrality
and consistency of responses across groups [30], we used
standardized semi-structured interview guides using the
same predetermined open-ended questions and moder-
ator prompts [31]. Interview questions queried partici-
pants about their pharmacy use preferences and the
perceived benefits and disadvantages of both mail order
and local pharmacies (please see the Additional file 1).
Focus groups were digitally recorded, professionally
transcribed verbatim, and deidentified prior to analysis.
To augment qualitative data and describe the sample, we
extracted demographic and clinical data from electronic
health records. The study was approved by the KPNC
Institutional Review Board; KPHI ceded Institutional Re-
view Board (IRB) oversight for this study to KPNC. A
completed ‘Standards for Reporting Qualitative Research’
checklist is included as supplemental material for
reference.
Qualitative data analysis
We employed thematic analysis [32] to inductively and
deductively derive themes from qualitative data [33]
using NVivo 11 software (QSR Intl Pty Ltd.; Doncaster,
Australia). We used the “Capability, Opportunity, Motiv-
ation, and Behavior” model (COM-B) [34] and closely
related, validated Theoretical Domains Framework
(TDF) [35, 36] to guide our qualitative analyses. These
frameworks synthesize leading theories of behavior
change, providing a systematic method for identifying
influences on a given behavior. One doctoral candidate
and two doctoral-level researchers in the fields of public
health and behavioral medicine reviewed all transcripts
to develop a coding scheme of broad meaningful
themes. Guided by the COM-B framework, we focused
on themes relevant to patients’ barriers and facilitators
enacting two target behaviors: using mail order phar-
macy and using a local pharmacy. We further defined
each target behavior as encompassing three individual
actions: requesting a prescription refill (e.g., in-person,
by phone, or online), paying for a prescription refill (e.g.,
using a credit card online), and receiving a prescription
refill (e.g., refilling it in-person from a pharmacist or re-
ceiving it in the mail). One researcher independently
coded each focus group transcript, with two of these
transcripts double-coded by a second researcher to pro-
mote reliability. Following the coding process, themes
were mapped to COM-B categories [34]: psychological
capability (e.g., knowledge of the mail order pharmacy
service); physical opportunity (e.g., the pharmacy loca-
tion); social opportunity (e.g., the opportunity to interact
with a pharmacist); automatic motivation (e.g., emo-
tional reactions, rewards); and reflective motivation (e.g.,
conscious beliefs and intentions). The research team dis-
cussed the text allocated to each theme, and the themes
allocated to each category, with discrepancies resolved
by consensus.
Results
Table 1 shows the demographic characteristics of study par-
ticipants (n = 28). Slightly more than half were female
(57%); the average age of participants was 64.1 years.
Thirty-six percent of patients were Asian, Native Hawaiian
or other Pacific Islander; 21% were Black/African-Ameri-
can; 7% were Hispanic/Latino, and 36% were non-Hispanic
White.
Table 2 shows the 26 qualitative themes that emerged
from the analysis, mapped to COM-B categories and
stratified by perceived barriers vs. facilitators of using
mail order pharmacy. As shown in Fig. 1, which displays
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the broad grouping of themes by COM-B category, most
themes (20/26) fell into the category of ‘Opportunity.’
Of those, 13 themes (65%) represented barriers. These
‘opportunity’ barriers included unpredictability of the
medication delivery date, concerns about mail security,
and difficulty coordinating refill orders for multiple pre-
scriptions. Patients’ quotes related to this theme appear
in italics; the focus group type (mail order user versus
(vs.) non-user), site, and participant number from which
they emerge follow in parentheses:
You don’t know when you going to get it. They cannot
give you a delivery date. […] I can’t do it, because I’m
too scared about that, […] it cost me too much, too
expensive to take that chance with insulin [of failing to
receive it on time]. (Non-user) KPNC, 6.
So there’s a little apprehension on my part, because
right now I currently live in a business district [where]
the mail gets tampered with. (Non-user) KPHI, 2.
And then, if your mailbox is not in a safe place –
because there’s been mail theft – you could lose
your drugs through mail theft. And if you paid for
the drug, I don’t know that they’re going to, you
know, replenish it even though it was stolen and
even though you paid for it. So those are the
drawbacks. (User) KPHI, 6.
Table 1 Demographic characteristics of focus group attendees
overall at Kaiser Permanente Northern California (KPNC) and
Kaiser Permanente Hawaii (KPHI) (n = 28)
Demographics n (%)
Female 16 (57%)
Age (mean, sd, range) 64.1, 10.0, 37–83
Race/Ethnicity
Asian/Native Hawaiian/Pacific Islander 10 (36%)
Black/African-American 6 (21%)
Non-Hispanic White 10 (36%)
Hispanic/Latino 2 (7%)
Mail Order Users 19 (68%)
Site
KPNC 16 (57%)
KPHI 12 (43%)
Table 2 Barriers and Facilitators to Refilling Medications Using Mail Order Pharmacy: Focus Group Themes Mapped to the Capability,
Motivation, Opportunity Model of Behavior Change (COM-B)
Barriers Facilitators
Capability Theme (#Focus groups; type)a Theme (#Focus groups; type)a
Psychological • Lack of knowledge about how mail order process works (4; user and non-user)
• Not planning ahead (3; user and non-user)
• Limited technological literacy (2; user and non-user)
Opportunity
Physical • Mail order system (e.g., online or phone) is unreliable, inconsistent, or hard to
navigate (2; user)
• Longer wait times when refill requires provider authorization (1; user)
• Wanting to use different forms of payment, but mail order system requires one
credit card to stay on file (1; non-user)
• Unpredictable delivery date (1; non-user)
• Difficult to coordinate refill dates for multiple prescriptions (1; user)
• Need for certain technology (e.g., computer) to use mail order system (2; user
and non-user)
• Concerns about mail security (e.g., possible theft) (4; user and non-user)
• Possibility of receiving refill ‘too late’ (i.e., after medication has run out) because
patients must time their order to match the mail order system’s allowable
window to order (1; user)
• Required to go to pharmacy if refill requires provider authorization (1; user)
• Mail order system cannot accommodate special requests (e.g., early refill due to
upcoming travel) (1; user)
• Inability to get refills immediately (i.e., same day) (1; user)
• Not all medications can be refilled through the mail order system (2; user)
• Mail order system is reliable, consistent, easy to
navigate (2; user)
• Arrives quickly in the mail (1; user)
• No lines or waiting in-person at pharmacy (2;
user)
• No travel required to obtain refill (2; user)
• Reminders to pick up refill from post office (1;
user)
• Notification from health system that refill is on
the way (1; user)
Social • No availability of in-person consultation with pharmacist (1; non-user) • Option to avoid negative interpersonal
interactions (e.g., with pharmacy staff) (1; user)
Motivation
Automatic • One-month supply of prescription refill is free
when using mail order (3; user and non-user)
Reflective • Belief that prescription may be negatively impacted (e.g., spoil, ‘go bad’) if left
outside upon delivery (2; user and non-user)
• Confidence in ability to use mail order system (2;
user)
aNumber of focus groups in which the theme emerged; type of focus group (mail order pharmacy user and/or non-user)
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I have eight prescriptions, and because of the change of
the medicines here and there, they’ve gotten all out of
sync. So, I’m ordering eight different times in a three-
month period, and that means I have to process eight
different claims with the insurance company to be re-
imbursed for them. (User) KPNC, 1.
In contrast, ‘opportunity’ facilitators included greater
access and convenience (e.g., no need to wait in line or
arrange transportation) compared to traditional pharma-
cies, and finding the mail order pharmacy system easy to
use. For example:
What’s good is that, once you’ve put in all your
information, you can just sort of hit the, you know, the
basic control [to automate the process]. So, like, your
credit card, you don’t have to put in numbers each
time. (User) KPHI, 2.
Kaiser’s website is very well organized and put
together, and it’s a breeze, really. (User) KPHI, 8.
Social opportunity factors—specifically, the ability to
avoid interactions with pharmacy staff— emerged as a
facilitator of mail order pharmacy use:
Which is why I would rather use the mail-order ser-
vice, because then you don’t have to deal with these
overworked clerks. (User) KPHI, 7.
Others described positive interactions with pharmacy
staff, and therefore viewed lack of interaction as a barrier
to using mail order pharmacy:
I have gone into the pharmacy, and they’ve, like, just
recently, they gave me a prescription…and I look at it
when I get it – it was different. Okay? Now, this
particular time, I was able to ask about it, and they
said, “Oh, they changed manufacturers, and it’s the
same medication.” But a couple of years ago, they had
actually given me the wrong one. And if that
happened with a mail order, and it’s something that I
needed, you couldn’t, like, right then fix it. (Non-user)
KPNC,5.
Within the ‘motivation’ category, barriers to using mail
order pharmacy included worry that prescriptions, in-
cluding diabetes-specific medications such as insulin,
would be negatively impacted (e.g., “go bad”) if left out-
side upon delivery:
So I was kind of concerned about that, if it sat in the
mailbox too long. Is it really effective, or is it
ineffective? (User) KPHI, 10.
Also, I don’t know how good it would be for insulin to
be shipped, because I don’t know how long it might sit
in my mailbox before I get to it…. because it’s supposed
to be kept cool…. And if it’s sitting in this tin mailbox
in the beating sun… – (Non-user) KPNC, 5.
In contrast, facilitators included confidence in one’s
ability to use the mail order pharmacy ordering system
and receiving an incentive of a free one-month supply of
medication each time a 3-month prescription was
ordered:
Well, previously, when you had the mail order, I did
participate. And, at that time, they offered, if you
ordered 90 days, you’d get 30 days free. I liked that
benefit. (Non-user) KPHI,2.
Further probing for the above patient confirmed that
they had used mail order pharmacy more than 12
months ago but were non-users during the 12month
look back window, and that repeated address and PO
box changes had discouraged them from using the ser-
vice more recently.
Fig. 1 Number of Focus Group Themes by COM-B Category
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…if they just going to approximate the way you’re
going to save money from parking or a bus or
whatever, things like that, it does – for me, it’s not
enough marketing to convince me….But if it’s real
savings, like it’s a lower cost to me, then I might look
at it. (Non-user) KPNC, 16.
“I think the best reason that nobody has mentioned
[within the focus group] yet is that you get the third
month free. And it’s a tremendous savings.”
(User)KPHI,2.
I started mail order for the free month. And when I
started, I was taking only two medications. Now I take
six, so if you listed how much savings, that, you know,
it would be in the hundreds of dollars that getting that
extra, you know, month for each medication. You
know, because I’m a type 2 diabetic. I’m a heart
patient. You know, so I take six medications a day. So
the savings for me is tremendous, you know? That’s
why I do mail order. And now, online, it’s so easy, you
know? It’s so easy that I can’t see another way to do it,
you know, because it would cost, you know, like I said,
a couple hundred dollars at least. (User) KPHI, 12.
Finally, within the ‘capability’ category, barriers in-
cluded lack of knowledge about how mail order phar-
macy works (e.g., the processes of ordering and delivery)
and lack of technological literacy:
If you need that certain medication that you have to
go down and sign for it, how are you going to get that
through the mail? [...] there’s some that they say is like
a [controlled] substance, like, pain and stuff like that.
To refill that, you have to go down to the pharmacy to
get it signed. How would you be able to get that
through the mail? The same, you know, for refills.
(Non-user) KPHI, 5.
I didn’t even know that you [could] call and [order]
over the phone…(User) KPHI, 2.
Not everybody is computer literacy, you know. So, like,
at my house, we have a computer, but I will say, “Hon,
can you do this for me? Hon, can you do that for me?”
But it’s where – if I go on a computer and I look for
prescriptions, I wouldn’t know which one to press.
(Non-user) KPHI, 8.
Discussion
Mail order pharmacy use is associated with better medi-
cation adherence and health care outcomes in diabetes
patients, but little is known about patients’ barriers and
facilitators to mail order use. Our focus groups and
qualitative analysis showed that some diabetes patients
may encounter important barriers to leveraging the op-
portunity to use mail order pharmacy, including difficul-
ties using the ordering system, order accuracy, concerns
about mail box security, longer waiting times for receiv-
ing medication compared to in-person refills, and con-
cerns that insulin delivery via mail would compromise
the safety and efficacy of the medication. One survey
study of patients between the ages of 65 and 79 found
that seniors’ concerns about mail order pharmacy use
included the potential for lost or stolen medications,
receiving the correct medication, and concerns that out-
door exposure may harm the prescription medication’s
efficacy [16]. Our study uncovered similar concerns, and
contributes to the evidence based with the new add-
itional finding that these concerns may apply to
diabetes-specific medications such as insulin. Another
study that interviewed veterans living with AIDS/HIV
found patients were concerned their medications might
run out before a new prescription fill arrived in the mail;
this finding was echoed in our analysis as well. Still,
prior studies suggest that mail order pharmacy users are
more satisfied with pharmacy services than traditional
community ‘brick and mortar’ pharmacy users [37–39];
addressing the barriers to mail order pharmacy use thus
has the potential to increase satisfaction while improving
health care outcomes and reducing costs. Health care
systems and pharmacy benefit managers should address
these issues to improve the patient experience and en-
courage mail order pharmacy use in those patients who
could benefit from the service.
Patients in our study cited numerous facilitators that
encouraged opportunities to use the mail order phar-
macy, including not having to wait in line in-person or
having to travel to the pharmacy to refill their medica-
tions. Patients whose benefits included a mail order
pharmacy incentive to receive an extra copayment’s
worth of medication day’s supply for free when paying
for two copayment’s worth (e.g. three for the price of
two) and using mail order saw this as a facilitator as
well. Since 90–100 day fills of diabetes medication are
standard in these settings, most diabetes patients eligible
for this incentive could likely benefit. This finding is
consistent with that of a prior focus group study focused
on understanding drug benefit decisions among adults
ages 65 and older, which found that access to mail order
pharmacy services was a valued attribute in prescription
drug plans [40]. Promoting these attributes that can en-
courage patients to consistently use mail order pharmacy
services, and expanding the drug benefit that allows for
greater days’ supply for similar cost when using mail
order, may be approaches to increase the uptake of pre-
scription home delivery [41].
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It is important to note that patients had a variety of per-
spectives on mail order pharmacy and themes occasionally
contradicted one another. For example, some patients felt
the mail order pharmacy system was unreliable and the de-
livery date unpredictable, whereas others felt the system was
reliable and cited delivery notifications as facilitating its use.
In another example, the need for in-person interactions with
pharmacists and staff was cited as both a barrier and facilita-
tor to mail order pharmacy use. Patients’ experience and un-
derstanding of mail order pharmacy services will not be
universal, and health care systems should target outreach
and communication to those who may be more in need of
information. In addition, mail order pharmacy services
should continue to offer the opportunity for one-on-one
consultations with pharmacists to address medication ques-
tions and concerns, and allow patients to fill prescriptions at
brick-and-mortar pharmacies in person if that is their per-
sonal preference [15].
This study has limitations that should be noted. The focus
group format and structure did not allow for understanding
differences in results by patient characteristics such as age,
gender, or socioeconomic status; prior studies suggest pref-
erence for mail order pharmacy vs. community pharmacy
may vary by some of these characteristics [17, 42]. However,
a strength of our study was the diversity of the participants
who participated in the focus groups; a majority were non-
Hispanic White. Social desirability bias in pharmacy services
research [43] may have led patients to underemphasize the
barriers to mail order pharmacy use within their health care
system. However, the number of barriers uncovered as well
as the consistency with prior research lends validity to these
results. This study defined non-users of mail order phar-
macy as those who had not used mail order for refills within
the past 12months; it is possible that “non-users” could have
had experience with mail order pharmacy in the more dis-
tant past.
This study focused on diabetes patients; patients with
other conditions may have different experiences with mail
order pharmacy. However, other studies of mail order phar-
macy use in patients with different chronic conditions have
found similar themes. This study took place in two inte-
grated delivery systems within the United States. Results
might not be fully generalizable to other health care delivery
systems, and the organizational roles and responsibilities for
improving mail order pharmacy services may be different in
other settings, particularly those that are less integrated or
that don’t operate their own pharmacy services. Finally, we
are unable to compare the effectiveness of the mail order
pharmacy services examined in this study to those in other
settings or countries, as these data are unavailable.
Conclusions
Our study found that while patients with diabetes may
benefit from mail order pharmacy use, they perceive
numerous barriers and facilitators to using the service.
These findings derived through this qualitative work,
can be used to design interventions and quality improve-
ment initiatives to increase mail order pharmacy use and
promote improved medication adherence and outcomes
in diabetes patients, across health care systems.
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